Morgan Joseph Reiterates a 'Buy' on Genzyme (GENZ); Favorable Risk Reward
Tweet Send to a Friend
Morgan Joseph reiterates a 'Buy' on Genzyme Corporation (Nasdaq: GENZ), price target $76.
Morgan analyst says, "Yesterday, GENZ reported Q110 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan analyst says, "Yesterday, GENZ reported Q110 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
